Bella Mira Essential Oil
Organic Carrier Oils
Essential Oil Information and Use
Express Order Form
Essential Oil Singles
Essential Oil Blends
Essential Oil Kits
Essential Oil Supplies
Gluten Free Living and Recipes
PAIN Relief and Information
Save Your Computer Free Protection
CD's DVD's and Books
Hormone Balance Test New
Thyroid Function Test
Internal Toxicity Test
Shopping Cart Is:
Prescription Drugs Can Deliver High Doses of Phthalates
For millions of people, medicines are a little-known, major source of the
compounds, which are linked to reproductive abnormalities. Scientists warn "of
the potential for high delivered doses of phthalates to vulnerable segments of
the population, particularly pregnant women or young children."
Every day for three months, the patient took a prescription drug called Asacol
to treat his inflamed colon.
Unbeknownst to him, every pill he swallowed also delivered a dose of a
hormone-altering, industrial chemical.
The man, who lived in the Boston area, was contaminated with about 100 times
more dibutyl phthalate than ever recorded before in a human being. His daily
dose of the chemical was double the amount that the U.S. Environmental
Protection Agency considers safe.
At least 47 prescription medications--including the colitis drug Asacol, an
antacid and an HIV drug--contain phthalates, according to scientists at the
Harvard School of Public Health and U.S. Centers for Disease Control and
Widely used as plasticizers, phthalates have been linked to abnormal
reproductive tracts, sperm damage and reduced testosterone in animal tests as
well as some human studies.
Russ Hauser, a Harvard professor of environmental epidemiology, called
pharmaceuticals "an unrecognized source of potential high exposure." A thin
layer of a phthalate-containing polymer, designed to slow the release of
medication, coats many timed-release drugs.
Phthalates are found in virtually every human body. But for people taking
medications coated with the compounds, their exposure exceeds other, well-known
sources, such as plastics, perfumes and lotions, by ten to 1,000-fold, Hauser
Phthalates are ingredients in vinyl, as well as some building materials, paints,
adhesives and personal care products, including fragrances, shampoos and nail
Congress enacted a law in August banning the chemicals in toys and other
But their use in prescription drugs and over-the-counter medications is approved
by the U.S. Food and Drug Administration.
New data showing high levels of phthalates in people taking some medications
"raise concern about potential human health risks," Hauser and his colleagues
reported in a study published in October in Environmental Health Perspectives
The scientists warned "of the potential for high delivered doses of phthalates
to vulnerable segments of the population, particularly pregnant women or young
In one case, the man taking Asacol for his ulcerative colitis, an inflammatory
bowel disease, had a concentration of a dibutyl phthalate (DBP) metabolite in
his urine measuring nearly 17,000 parts per billion, according to a case study
reported by the Harvard/CDC team. The average for the general population was 46.
The unidentified man, in his early 30s, was tested for phthalates as part of a
visit to a Boston infertility clinic. He and his wife were unable to conceive a
The effects of phthalates on male fertility remain unknown, but some scientists
theorize that exposure, especially in the womb, could contribute to an increase
in men's reproductive disorders, such as reduced sperm quality, testicular
cancer and undescended testicles.
Representatives of the plastics industry say the levels of phthalates used in
consumer products are safe. They say human studies are small and inconclusive,
and that the animals in studies showing effects were exposed to high doses.
The FDA has not put restrictions on use of phthalates except for a 2001
guideline that warned hospitals that phthalate-containing intravenous tubing and
other plastic medical devices exposes infants to large doses of the chemicals.
Dr. Shanna Swan, a professor of obstetrics and gynecology and of environmental
medicine at University of Rochester, called DBP, used in Asacol, "one of the
most toxic" phthalates. It was associated with feminization of newborn boys--a
shortened distance between the genitals and the anus-in a study that Swan and
her colleagues published in 2005.
About 20 million prescriptions for Asacol have been written in the United States
since it was approved by the FDA in 1992, according to Procter & Gamble
Pharmaceuticals, the drug's manufacturer.
"DBP is an important component of our enteric coating, which ensures that Asacol
is delivered to the site of inflammation in the colon and/or rectum," said Scott
Docherty, external relations manager for Procter & Gamble Pharmaceuticals.
Without the phthalate coating, which dissolves when it reaches a certain pH, the
drug would be released in the stomach. Because DBP has been approved by the FDA,
the company is not looking for alternatives, Docherty said.
P&G's surveillance of patients "has not identified any adverse events or
effects" caused by the DBP, he said.
The Boston area man was prescribed an extraordinary dosage of Asacol--12 pills a
day, which is double the highest recommended dose on the manufacturer's label.
He took it for three months, twice as long as recommended.
Docherty said for patients taking the recommended doses of Asacol, their DBP
exposure is far below the EPA's "no observed effects level."
"If the patient follows the labeled dose, even the highest dose on the label,
they would be taking six tablets per day and there would still be a safety
margin 100-fold below" the EPA's guideline, Docherty said.
But Hauser's team recently found other examples of high exposure, although not
as extreme as that man's.
The scientists analyzed a national database of 8,000 people, and found six,
including a pregnant woman, who took mesalamine, the active ingredient in Asacol.
They averaged 50 times more DBP metabolite in their urine than people who did
not take the drug, and two exceeded the EPA's no-effects level, the October
Another 121 people who took three other medications--omeprazole, used in
Prilosec antacids; didanosine, which is sold under the name Videx EC and treats
HIV patients; and theophylline, a pulmonary disease medicine-also had
above-average levels of another phthalate, up to eight times higher than people
who did not take the drugs.
Swan cautioned that the Harvard/CDC study included small numbers of people
taking the drugs so the averages may be distorted by a few highly exposed ones.
Nevertheless, Swan, who did not participate in the study, said the data suggest
that millions of people could be at risk.
Baby boys exposed in the womb may be the most vulnerable, Hauser and Swan said.
At least three women in the study with above-average phthalate levels were
pregnant-one was taking mesalamine and two were taking the antacids, said Sonia
Hernandez-Diaz, a Harvard associate professor of epidemiology who was the
study's lead author. Another woman of childbearing age who took the colitis drug
had a daily dose of DBP exceeding the EPA's guideline.
"We know that high doses of DBP given to pregnant rats can lead to reproductive
tract anomalies in the male offspring. Therefore, I would be concerned about
high DBP exposure in pregnant women," Hauser said.
When prescribing medications to pregnant women, doctors should seek formulations
free of the compounds, he said.
Many people who take the medicines have a serious disease that may make them
more susceptible to chemicals. HIV patients, for example, have a suppressed
The authors reported that their study "probably underestimates the true impact
of exposure to phthalates in medications."
Most notably, they did not study over-the-counter medications and vitamins,
which often have timed-release coatings.
"I think there are likely other medications that also contribute to very high
human exposure," Hauser said, adding that the number of problematic medications
"is likely to change, up or down, depending on what we learn in the coming
I have emailed Prof. Hauser to get the complete list. As prescription drugs
are not required to list 100% of their ingredients ( due to the proprietary
rights labeling laws) you cannot find out what prescription and over the counter
drugs contains phthalates. When I get the list I will list it here.
The ones listed in the text include:
Prilosec, Asacol, theophylline, Videx EC
However anything timed release or plastic coated could contain phthalates.
You can always ask your pharmacist for complete ingredients of your prescription
but it wont help much. Your best bet is to reduce taking prescriptions as much
as possible as well as OTC drugs. This include herbals or other supplements that
are timed release. If you must take prescriptions such as thyroid medications or
hormones your only sure fire way to make sure they are phthalate- free is to use
a customizing pharmacy and have the active ingredients put into a gel cap.
Vegetarian caplets contain phthalates and are plastic. Hormones can be made as a
cream but most cream bases contain propylene glycol, SLS, and phthalates. You
can also bring in your own cream to have them use I do that.